It’s the most wonderful time of the year... to check out the epidemiology, genetics, and biostatistics fellowships in #CancerResearch that NCI Cancer Epidemiology and Genetics has to offer! https://lnkd.in/gi3QkwVk
National Cancer Institute (NCI)
Government Administration
Bethesda, MD 318,680 followers
The National Cancer Institute, part of the National Institutes of Health, is the lead federal agency for cancer research
About us
The National Cancer Institute (NCI), part of the National Institutes of Health, is the lead federal agency for cancer research. For more information about NCI, visit us at www.cancer.gov. Privacy policy: https://www.cancer.gov/policies/privacy-security Engagement ≠ endorsement
- Website
-
http://www.cancer.gov
External link for National Cancer Institute (NCI)
- Industry
- Government Administration
- Company size
- 1,001-5,000 employees
- Headquarters
- Bethesda, MD
- Type
- Government Agency
- Specialties
- cancer, cancer research, cancer training, cancer research grants, cancer resources, cancer information, and cancer research funding
Locations
-
Primary
Get directions
9000 Rockville Pike
Bethesda, MD 20892, US
-
Get directions
9609 Medical Center Drive
Rockville, MD 20850, US
-
Get directions
Ft. Detrick U.S. Army Facility
Frederick, MD, US
Employees at National Cancer Institute (NCI)
Updates
-
Some men receiving radiation therapy for prostate cancer can have their treatment compressed into just 5 sessions, compared with the minimum of 20 that is often used, according to results from a large clinical trial. Find out more about the trial results. https://go.nih.gov/IyiAgYd
-
Attention researchers: Explore the latest release of the Childhood Cancer Clinical Data Commons (C3DC), which includes new and updated data sets and introduces a feature called the Cohort Selector. These and other updates are designed to optimize data exploration and enhance user experience, making harmonized pediatric clinical data within the C3DC more accessible and valuable for research. Access the C3DC today. https://go.nih.gov/kmNxNpO #Data4ChildhoodCancer
Childhood Cancer Clinical Data Commons
clinicalcommons.ccdi.cancer.gov
-
Ready to transform how you work with unstructured EHR data? Join a CCDI webinar with Dr. David Hanauer from the University of Michigan Medical School on EMERSE, a powerful tool for non-technical users that simplifies tasks like cohort identification and data abstraction. Register today. https://go.nih.gov/7NeN90g #Data4ChildhoodCancer
-
-
National Cancer Institute (NCI) reposted this
Today, Dr. Vivek Murthy released a Surgeon General’s Advisory on the causal link between alcohol consumption and increased cancer risk. With about 20,000 alcohol-related cancer deaths per year in the U.S., we must increase awareness of the risks of alcohol consumption. Read more: https://lnkd.in/ej_Sj8hY
-
-
National Cancer Institute (NCI) reposted this
Starting the new year off right with the message "Dare to Invest in Women's Health" with Daré Bioscience, Inc.! Thank you to everyone at Nasdaq for the incredible event. https://lnkd.in/esPNjrXF
-
-
-
-
-
+1
-
-
In this podcast, NCI’s Dr. Jill Barnholtz-Sloan discusses her science background and advice for careers in #CancerResearch. She also talks about essential skills you should develop if you’re computationally and quantitatively inclined. Check it out! https://go.nih.gov/Qa9adyk
-
-
Our Halloween post is one of NCI's #BestOf2024! ⤵️ Talk about spooky science! 👻 In a recent study, researchers designed a molecule that tricks blood cancer cells into self-destructing - like something out of a horror movie for cancer cells! Experts say the molecule represents a new class of compounds that could have broad potential as cancer treatments. No magic potions here, just cutting-edge cancer research at work. 🎃 https://go.nih.gov/UXMaRlg #NCIhighlights2024
Drug Turns on Self-Destruct Genes in Cancer Cells
cancer.gov
-
The FDA recently granted accelerated approval to tarlatamab (Imdelltra) for some individuals with small cell lung cancer, the most aggressive form of lung cancer. Learn more: https://go.nih.gov/ND04aus #NCIhighlights2024 #BestOf2024 Media Description: Tarlatamab is a bispecific T-cell engager (BiTE), a two-armed drug that simultaneously latches onto tumor cells and T cells, bringing them close together and helping the T cells recognize and destroy cancer cells. Credit: Adapted and used with permission from Amgen.
-
-
National Cancer Institute (NCI) reposted this
On my blog this week: exploring valuable information we’ve learned about how cancer tumors develop, spread and respond to treatments. The new data is available thanks to an NIH-funded Cancer Moonshot initiative to construct 3-D maps of human tumors. Read more: https://lnkd.in/gxDsTFEA #cancer #CancerResearch #CancerMoonshot #research #NIH
Human Tumor Atlases Provide Important Insights into How Cancer Tumors Develop and Spread
Monica Bertagnolli on LinkedIn